All data are based on the daily closing price as of October 8, 2026
e

Euglena

2931.TSE
2.12 USD
-0.01
-0.47%

Overview

Last close
2.12 usd
Market cap
295.42M usd
52 week high
3.46 usd
52 week low
1.97 usd
Target price
2.53 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.8985
Price/Book Value
1.4716
Enterprise Value
345.86M usd
EV/Revenue
1.0456
EV/EBITDA
8.3671

Key financials

Revenue TTM
330.77M usd
Gross Profit TTM
228.98M usd
EBITDA TTM
42.18M usd
Earnings per Share
-0.01 usd
Dividend
0.01 usd
Total assets
426.12M usd
Net debt
59.37M usd

About

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and social businesses; and invests in biotechnology related businesses. Further, the company provides genome analysis services. Euglena Co., Ltd. was incorporated in 2005 and is headquartered in Tokyo, Japan.
  • Symbol
    2931.TSE
  • Exchange
    TSE
  • Isin
    JP3944370000
  • Country
    Japan
  • Sector
    Consumer Defensive
  • Industry
    Household & Personal Products
  • CEO
    Mr. Tomohiro Wakahara
  • Headquarter
    Tokyo
  • Web site
    https://www.euglena.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top